{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:59:39Z","timestamp":1790510379132,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.expneurol.2004.11.017","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T17:49:07Z","timestamp":1109353747000},"page":"469-480","source":"Crossref","is-referenced-by-count":104,"title":["Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice"],"prefix":"10.1016","volume":"193","author":[{"given":"Hyemyung","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.11.017_bib1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/hmg\/10.18.1915","article-title":"Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome","volume":"10","author":"Altafaj","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2004.11.017_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1460-9568.2000.00956.x","article-title":"Afferent-specific modulation of short-term synaptic plasticity by neurotrophins in dentate gyrus","volume":"12","author":"Asztely","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib3","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1001\/jama.282.23.2208","article-title":"Cholinergic markers in Alzheimer disease","volume":"282","author":"Bartus","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2004.11.017_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.54.10.1907","article-title":"Platelet APP isoform ratios correlate with declining cognition in AD","volume":"54","author":"Baskin","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.11.017_bib5","first-page":"133","article-title":"Growth and development of the brain in Down syndrome","volume":"373","author":"Becker","year":"1991","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0169-328X(99)00014-5","article-title":"Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein","volume":"66","author":"Berger-Sweeney","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0304-3940(02)00442-1","article-title":"Spatial memory testing decreases hippocampal amyloid precursor protein in young, but not aged, female rats","volume":"328","author":"Bimonte","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2004.11.017_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-4328(02)00082-7","article-title":"Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome","volume":"139","author":"Bimonte-Nelson","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/exnr.2001.7700","article-title":"Selective antibody-induced cholinergic cell and synapse loss produce sustained hippocampal and cortical hypometabolism with correlated cognitive deficits","volume":"170","author":"Browne","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib10","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1073\/pnas.97.12.6826","article-title":"Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice","volume":"97","author":"Capsoni","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.11.017_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/mcne.2002.1163","article-title":"Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies","volume":"21","author":"Capsoni","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib12","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1073\/pnas.192442999","article-title":"Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice","volume":"99","author":"Capsoni","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.11.017_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ana.410180306","article-title":"Abnormalities of the nucleus basalis in Down's syndrome","volume":"18","author":"Casanova","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib14","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1073\/pnas.181219298","article-title":"Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion","volume":"98","author":"Cooper","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.11.017_bib15","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1523\/JNEUROSCI.13-06-02540.1993","article-title":"Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease","volume":"13","author":"Crutcher","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib16","series-title":"The Phenotypic Mapping of Down Syndrome and Other Aneuploid Conditions","first-page":"117","article-title":"Segmental trisomy as a model for Down syndrome and other aneuploid conditions","author":"Davisson","year":"1993"},{"key":"10.1016\/j.expneurol.2004.11.017_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0166-4328(97)81111-4","article-title":"Spatial memory deficits in segmental trisomic Ts65Dn mice","volume":"82","author":"Demas","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0165-3806(96)00071-5","article-title":"Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model","volume":"95","author":"Dierssen","year":"1996","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-8993(96)01173-0","article-title":"Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome","volume":"749","author":"Dierssen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib20","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1523\/JNEUROSCI.22-07-02571.2002","article-title":"Failure of brain-derived neurotrophic factor-dependent neuron survival in mouse trisomy 16","volume":"22","author":"Dorsey","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib21","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/BF01941286","article-title":"Developmental genetics","volume":"42","author":"Epstein","year":"1986","journal-title":"Experientia"},{"key":"10.1016\/j.expneurol.2004.11.017_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0169-328X(96)00193-3","article-title":"Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex","volume":"42","author":"Fahnestock","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-7091-6139-5_22","article-title":"Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?","author":"Fahnestock","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2004.11.017_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.1975.tb11895.x","article-title":"A rapid and sensitive method for the determination of choline acetyltransferase","volume":"24","author":"Fonnum","year":"1975","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.11.017_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0169-328X(99)00048-0","article-title":"Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine","volume":"67","author":"French","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1046\/j.1471-4159.2002.01030.x","article-title":"A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex","volume":"82","author":"Garzon","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.11.017_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0169-328X(86)90023-9","article-title":"Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease","volume":"387","author":"Goedert","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1006\/exnr.1999.7289","article-title":"Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome","volume":"161","author":"Granholm","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2004.11.017_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000007917","article-title":"Cerebrospinal fluid levels of amyloid precurser protein and amyloid \u03b2-peptide in Alzheimer's disease and major depression-inverse correlation with dementia severity","volume":"39","author":"Hock","year":"1998","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","article-title":"Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease","volume":"76","author":"Holsinger","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1073\/pnas.89.4.1383","article-title":"Mouse model of neurodegeneration: Atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants","volume":"89","author":"Holtzman","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.11.017_bib33","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","article-title":"Developmental abnormalities and aged-related neurodegeneration in a mouse model of Down syndrome","volume":"93","author":"Holtzman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.11.017_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-4328(02)00275-9","article-title":"Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory","volume":"138","author":"Hunter","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib35","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1037\/0735-7044.115.6.1239","article-title":"Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease","volume":"115","author":"Hyde","year":"2001","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-2236(02)02037-4","article-title":"Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh","volume":"25","author":"Isacson","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2818.1993.tb03321.x","article-title":"The rotator","volume":"170","author":"Jensen","year":"1993","journal-title":"J. Microsc."},{"key":"10.1016\/j.expneurol.2004.11.017_bib38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.11.017_bib39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/cercor\/10.10.981","article-title":"Dendritic anomalies in disorders associated with mental retardation","volume":"10","author":"Kaufmann","year":"2000","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2004.11.017_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(00)01984-3","article-title":"Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice","volume":"858","author":"Kurt","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/096368979900800105","article-title":"Morris water maze analysis of 192-IgG\u2013saporin-lesioned rats and porcine cholinergic transplants to the hippocampus","volume":"8","author":"LeBlanc","year":"1999","journal-title":"Cell Transplant"},{"key":"10.1016\/j.expneurol.2004.11.017_bib42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001756-199802160-00030","article-title":"Chronic cognitive deficits and amyloid precursor protein elevation after immunotoxin lesions of the basal forebrain cholinergic system","volume":"9","author":"Lin","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2004.11.017_bib43","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.1073\/pnas.96.21.12108","article-title":"Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation","volume":"96","author":"Lin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.11.017_bib44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/77702","article-title":"Maternal care, hippocampal synaptogenesis and cognitive development in rats","volume":"3","author":"Liu","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02340121","article-title":"Nerve growth factor (NGF) in cerebrospinal fluid (CSF) from patients with various neurological disorders","volume":"15","author":"Massaro","year":"1994","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib46","first-page":"337","article-title":"Signaling events regulating the neurodevelopmental triad. Glutamate and secreted forms of beta-amyloid precursor protein as examples","volume":"5","author":"Mattson","year":"1998","journal-title":"Perspect. Dev. Neurobiol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00001756-199505090-00028","article-title":"Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis","volume":"6","author":"Mufson","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2004.11.017_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0306-4522(95)00431-9","article-title":"Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons","volume":"71","author":"Mufson","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.11.017_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/exnr.1997.6504","article-title":"Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease","volume":"146","author":"Mufson","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(86)90082-8","article-title":"The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist","volume":"125","author":"Palacios","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0006-8993(02)03009-3","article-title":"Pilocarpine-induced seizure-like activity with increased BNDF and neuropeptide Y expression in organotypic hippocampal slice cultures","volume":"950","author":"Poulsen","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behaviour deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2004.11.017_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0301-0082(98)00044-6","article-title":"The regulation of amyloid precursor protein metabolism by cholinergic mechanism and neurotrophin receptor signaling","volume":"56","author":"Rossner","year":"1998","journal-title":"Prog. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib54","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0022-510X(92)90031-F","article-title":"Comparison of the effects of selective and nonselective muscarinic agonist on cognition and thermoregulation in primates","volume":"110","author":"Rupniak","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0079-6123(08)64009-1","article-title":"Neurotrophin receptors in Alzheimer's disease","volume":"117","author":"Salehi","year":"1998","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/cne.10449","article-title":"Structural and functional asymmetry in the normal and epileptic rat dentate gyrus","volume":"454","author":"Scharfman","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib57","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.15-09-06213.1995","article-title":"Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis","volume":"15","author":"Scott","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib58","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.0953-816x.2001.01884.x","article-title":"Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice","volume":"15","author":"Seo","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib59","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.1523\/JNEUROSCI.22-22-09794.2002","article-title":"Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis","volume":"22","author":"Sheng","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib60","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0028-3908(97)00157-3","article-title":"Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome","volume":"36","author":"Siarey","year":"1997","journal-title":"Neuropharmacology"},{"issue":"Pt. 3","key":"10.1016\/j.expneurol.2004.11.017_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2788.1994.tb00394.x","article-title":"Dendritic and histochemical development and ageing in patients with Down's syndrome","volume":"38","author":"Takashima","year":"1994","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib62","first-page":"63","article-title":"Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer's disease","volume":"6","author":"Van Gool","year":"1995","journal-title":"Dementia"},{"key":"10.1016\/j.expneurol.2004.11.017_bib63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0014-2999(90)90374-F","article-title":"Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM 796 and YM954","volume":"187","author":"Wanibuchi","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02736773","article-title":"Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient","volume":"6","author":"West","year":"1995","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1749-6632.1986.tb40344.x","article-title":"Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome","volume":"477","author":"Wisniewski","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2004.11.017_bib66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.410170310","article-title":"Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome","volume":"17","author":"Wisniewski","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.11.017_bib67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-8993(83)91179-4","article-title":"Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome","volume":"280","author":"Yates","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.11.017_bib68","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/(SICI)1097-4547(19961201)46:5<581::AID-JNR7>3.0.CO;2-F","article-title":"Detection of increased tissue concentrations of nerve growth factor with an improved extraction procedure","volume":"46","author":"Zettler","year":"1996","journal-title":"J. Neurosci. Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604004352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604004352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T19:35:04Z","timestamp":1706038504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604004352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0014488604004352"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.017","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}